株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インドネシアの医薬品・医療産業(四半期更新レポート)

Indonesia Pharmaceuticals and Healthcare Report Q2 2017

発行 BMI Research 商品コード 177846
出版日 ページ情報 英文 124 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=112.29円で換算しております。
Back to Top
インドネシアの医薬品・医療産業(四半期更新レポート) Indonesia Pharmaceuticals and Healthcare Report Q2 2017
出版日: 2017年03月01日 ページ情報: 英文 124 Pages
担当者のコメント
このシリーズは、他にも調査対象国がございます。詳細はお問合せください。
概要

当レポートでは、インドネシアにおける製薬・医療産業の構造や最新動向について分析し、今後10年間の産業規模の動きを推計すると共に、業界の抱える課題(リスク)や将来的な収益機会(リワード)に関する評価、政府の政策・規制、マクロ経済環境、主要企業のプロファイルといった情報を盛り込んでお届けします。

BMIの見解

SWOT分析

産業予測

  • 医薬品市場の予測
  • 医療市場の予測
  • 処方薬市場の予測
  • 特許薬市場の予測
  • ジェネリック医薬品市場の予測
  • OTC医薬品市場の予測
  • 医薬品の対外貿易状況

産業のリスク/リワード・レーティング

  • アジア太平洋地域:リスク/リワード・レーティング
  • インドネシア:リスク/リワード・レーティング
    • リワード
    • リスク

規制のレビュー

  • 知的財産権に関する課題
  • 薬価
  • 償還

産業の動向と発展

  • 市場概要
  • 医療部門
  • 研究開発
  • 治験
  • 疫学

競合情勢

  • 研究開発
  • ジェネリック医薬品
  • 医薬品の流通部門
  • 医薬品の小売部門

企業プロファイル

人口動態の予測

  • 人口動態の見通し

用語集

調査手法

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 1748-1945

BMI View: Indonesia's pharmaceutical sector will see continued foreign investment. Spurring even greater investment has been the relaxation of foreign ownership restrictions in both the 2014 and 2016 and revisions to the negative investment lists. This is further reinforced by regulations pushing for the localisation of pharmaceuticals, as well as by the attractiveness of the Indonesian market as the largest in South East Asia.

Headline Expenditure Projections

  • Pharmaceuticals: IDR85bntrn (USD6.4bn) in 2016 to IDR94trn (USD6.7bn) in 2017; +10.1% growth in local currency terms and +4.6 in US dollar terms.
  • Healthcare: IDR366trn (USD27bn) in 2016 to IDR406trn (USD28bn) in 2017; +10.9% growth in local currency terms and +5.4% in US dollar terms.

Risk/Reward Index

Indonesia ranks 11 out of 20 Asia Pacific markets on BMI's Pharmaceutical Risk/Reward Index, scoring 49.5 out of 100 in Q217. While the country has positive industry rewards, scoring 24.8 out of 44.0, it is dragged down by a low Country Reward score (10.2 out of 21), as well as higher Industry Risks (scoring 8.4 out of 21) and Country Risks (scoring 6.5 out of 14) scores.

Table of Contents

BMI Industry View

  • Table: Headline Pharmaceuticals & Healthcare Forecasts (Indonesia 2015-2021)
  • SWOT

Industry Forecast

  • Pharmaceutical Market Forecast
    • Table: Pharmaceutical Sales, Historical Data And Forecasts (Indonesia 2013-2021)
  • Healthcare Market Forecast
    • Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2013-2021)
    • Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2013-2021)
    • Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2013-2021)
  • Prescription Drug Market Forecast
    • Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Indonesia 2013-2021)
  • Patented Drug Market Forecast
    • Table: Patented Drug Market Indicators, Historical Data And Forecasts (Indonesia 2013-2021)
  • Generic Drug Market Forecast
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Indonesia 2013-2021)
  • OTC Medicine Market Forecast
    • Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Indonesia 2013-2021)
  • Pharmaceutical Trade Forecast
    • Table: Pharmaceutical Trade Data And Forecasts (Indonesia 2015-2021)
    • Table: Pharmaceutical Trade Data And Forecasts local currency (Indonesia 2015-2021)

Industry Risk/Reward Index

  • Asia Pacific Risk/Reward Index
  • Indonesia Risk/Reward Index
    • Rewards
    • Risks

Regulatory Review

  • Intellectual Property Issues
  • Pricing Regime
  • Reimbursement Regime

Industry Trends And Developments

  • Market Overview
    • Table: UN Millennium Development Goals For Indonesia
  • Healthcare Sector
    • Table: Examples Of JKN Benefits
    • Table: Healthcare Resources (Indonesia 2011-2016)
    • Table: Healthcare Personnel (Indonesia 2011-2016)
    • Table: Healthcare Activity (Indonesia 2011-2016)
  • Research & Development
  • Clinical Trials
  • Epidemiology
    • Table: Estimated Number Of New Cases Of Cancer In Indonesia

Competitive Landscape

  • Research-Based Industry
    • Table: Selected List Of Pharmaceutical Business Areas With Restricted Conditions
    • Table: Multinational Market Activity
  • Generic Drugmakers
  • Pharmaceutical Distribution
  • Pharmaceutical Retail Sector

Company Profile

  • Bayer
  • Darya-Varia Group
  • GlaxoSmithKline
  • Indopharma
  • Kimia Farma
  • Merck & Co
  • Merck Group
  • Novartis
  • Pfizer
  • PT Biofarma
  • PT Kalbe Farma
  • Sanofi
  • Soho Group

Demographic Forecast

  • Demographic Outlook
    • Table: Population Headline Indicators (Indonesia 1990-2025)
    • Table: Key Population Ratios (Indonesia 1990-2025)
    • Table: Urban/Rural Population & Life Expectancy (Indonesia 1990-2025)
    • Table: Population By Age Group (Indonesia 1990-2025)
    • Table: Population By Age Group % (Indonesia 1990-2025)

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
  • Index Overview
    • Table: Pharmaceutical Risk/Reward Index Indicators
  • Indicator Weightings
Back to Top